EcoDrugPlus

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma

Ensembl ID : ENSACLG00000003623
Gene Symbol: PIK3CG
3 Cross references
216 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSACLG00000026140
Gene Symbol: PDE10A
3 Cross references
207 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSACLG00000005073
Gene Symbol: PDE3A
2 Cross references
183 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSACLG00000021685
Gene Symbol: PDE3A
3 Cross references
203 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSACLG00000026994
Gene Symbol: PDE3B
3 Cross references
204 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSACLG00000018415
Gene Symbol: PDE4A
1 Cross references
180 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSACLG00000009693
Gene Symbol: PDE4B
3 Cross references
226 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSACLG00000013600
Gene Symbol: PDE4B
3 Cross references
224 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSACLG00000016020
Gene Symbol: PDE4D
3 Cross references
222 Possible Orthologues:

Phosphodiesterase 5a

Ensembl ID : ENSACLG00000005554
Gene Symbol: PDE5A
4 Cross references
208 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSACLG00000026048
Gene Symbol: PDE7A
3 Cross references
215 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSACLG00000010402
Gene Symbol: PDE7B
4 Cross references
174 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).